A STUDY TO ASSESS THE BIOEQUIVALENCE OF 2 FIXED DOSE COMBINATION (FDC) TABLETS OF CANAGLIFLOZIN AND METFORMIN IMMEDIATE RELEASE (IR) (50 MG/1,000 MG) WITH RESPECT TO THE INDIVIDUAL COMPONENTS OF CANAGLIFLOZIN (1 X 100 MG) AND METFORMIN IR TABLETS (2 X 1,000 MG) IN HEALTHY VOLUNTEERS: